TRANSCRIPTION OF PLASMINOGEN ACTIVATOR INHIBITOR, MODULATOR OF
|
phenotype |
|
Finding
|
1
|
1
|
0.300 |
strong |
|
0 |
1
|
|
|
Menorrhagia
|
phenotype |
Pathological Conditions, Signs and Symptoms; Female Urogenital Diseases and Pregnancy Complications
|
Pathologic Function
|
34
|
6
|
0.100 |
None |
|
0 |
|
|
|
nervous system disorder
|
group |
Nervous System Diseases
|
Disease or Syndrome
|
977
|
39
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Hyalinosis, Segmental Glomerular
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
28
|
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Diabetes Mellitus, Experimental
|
disease |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Experimental Model of Disease
|
522
|
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Hereditary Diffuse Gastric Cancer
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
312
|
119
|
0.300 |
None |
1.000 |
1 |
|
2006 |
2006 |
Respiratory Hypersensitivity
|
phenotype |
Respiratory Tract Diseases; Immune System Diseases
|
Pathologic Function
|
23
|
|
0.300 |
None |
1.000 |
1 |
|
2014 |
2014 |
Atherogenesis
|
phenotype |
Cardiovascular Diseases
|
Pathologic Function
|
59
|
|
0.300 |
None |
1.000 |
1 |
|
2002 |
2002 |
Heart Failure, Right-Sided
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
154
|
|
0.300 |
None |
1.000 |
1 |
|
2012 |
2012 |
Alloxan Diabetes
|
disease |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Experimental Model of Disease
|
112
|
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Myocardial Failure
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
119
|
|
0.300 |
None |
1.000 |
1 |
|
2012 |
2012 |
Liver diseases
|
group |
Digestive System Diseases
|
Disease or Syndrome
|
1019
|
100
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
Malignant neoplasm of liver
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
1649
|
88
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Streptozotocin Diabetes
|
disease |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Experimental Model of Disease
|
112
|
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Cholestasis
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
420
|
15
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Nodular glomerulosclerosis
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
59
|
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Left-Sided Heart Failure
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
123
|
5
|
0.300 |
None |
1.000 |
1 |
|
2012 |
2012 |
Heart Decompensation
|
phenotype |
Cardiovascular Diseases
|
Pathologic Function
|
113
|
|
0.300 |
None |
1.000 |
1 |
|
2012 |
2012 |
Liver Dysfunction
|
phenotype |
Digestive System Diseases
|
Finding
|
73
|
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
Neointima
|
disease |
Pathological Conditions, Signs and Symptoms
|
Acquired Abnormality
|
40
|
|
0.200 |
None |
1.000 |
1 |
|
2007 |
2007 |
Polycythemia
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
82
|
22
|
0.200 |
None |
1.000 |
1 |
|
1997 |
1997 |
Thoracoabdominal aortic aneurysm, ruptured
|
disease |
Cardiovascular Diseases; Wounds and Injuries
|
Disease or Syndrome
|
5
|
|
0.200 |
None |
1.000 |
1 |
|
1998 |
1998 |
Arterial thrombosis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Pathologic Function
|
33
|
1
|
0.200 |
None |
1.000 |
1 |
|
2016 |
2016 |
Pulmonary Hypertension
|
phenotype |
Respiratory Tract Diseases
|
Pathologic Function
|
156
|
|
0.200 |
None |
1.000 |
1 |
|
2016 |
2016 |
Hematological Disease
|
group |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
255
|
16
|
0.200 |
None |
1.000 |
1 |
|
2010 |
2010 |